DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 121 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2019. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $115 | -99.9% | 10,769 | 0.0% | 0.00% | – |
| Q3 2022 | $112,000 | -21.1% | 10,769 | -4.6% | 0.00% | – |
| Q2 2022 | $142,000 | -3.4% | 11,283 | -16.8% | 0.00% | – |
| Q1 2022 | $147,000 | -23.0% | 13,560 | 0.0% | 0.00% | – |
| Q4 2021 | $191,000 | -26.5% | 13,560 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $260,000 | +237.7% | 13,560 | -36.9% | 0.00% | – |
| Q3 2019 | $77,000 | -14.4% | 21,500 | -4.4% | 0.00% | – |
| Q2 2019 | $90,000 | -45.1% | 22,500 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $164,000 | +2.5% | 22,500 | +28.6% | 0.00% | 0.0% |
| Q4 2018 | $160,000 | +17.6% | 17,500 | +59.1% | 0.00% | 0.0% |
| Q3 2018 | $136,000 | +27.1% | 11,000 | +57.1% | 0.00% | – |
| Q2 2018 | $107,000 | +46.6% | 7,000 | +89.2% | 0.00% | – |
| Q1 2018 | $73,000 | +284.2% | 3,700 | +270.0% | 0.00% | – |
| Q4 2017 | $19,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
| Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
| PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
| Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
| Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
| FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
| FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
| Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
| OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |